Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APPY talk: is Venaxis's appendicitis test finally set for approval?

This article was originally published in Clinica

Executive Summary

After many setbacks, Venaxis is hopeful that its APPY1 appendicitis test could soon be cleared by the US FDA. The company has just reported what it says are positive top-line results from its pivotal trial: it found a negative predictive value (NPV) of 97%, sensitivity of 97% and specificity of 38%.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101417

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel